Linahert 5 (Linagliptin) works to control blood sugar levels in type 2 diabetes mellitus by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4). DPP-4 breaks down incretin hormones, which are responsible for stimulating insulin release in response to meals. By inhibiting DPP-4,
Linahert 5 (linagliptin) increases the levels of active incretin hormones, leading to enhanced insulin secretion from the pancreas and decreased glucagon release. This helps lower blood glucose levels, particularly after meals, and improves overall glycemic control without causing significant hypoglycemia.